Mark J. Ratain to Patient Safety
This is a "connection" page, showing publications Mark J. Ratain has written about Patient Safety.
Connection Strength
0.392
-
Playing Russian roulette with tyrosine kinase inhibitors. Clin Pharmacol Ther. 2013 Mar; 93(3):242-4.
Score: 0.354
-
Weight-Based Dosing of Pembrolizumab Every 6 Weeks in the Time of COVID-19. JAMA Oncol. 2020 11 01; 6(11):1694-1695.
Score: 0.038